These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2495847)

  • 1. Prostaglandins, cyclo-oxygenase inhibitors, and thromboxane synthetase inhibitors in the pathogenesis of multiple systems organ failure.
    Petrak RA; Balk RA; Bone RC
    Crit Care Clin; 1989 Apr; 5(2):303-14. PubMed ID: 2495847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo models for evaluating drugs which influence arachidonic acid metabolism.
    Gryglewski R
    Agents Actions Suppl; 1979; (4):82-95. PubMed ID: 115261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and regional hemodynamic effects of cyclo-oxygenase and thromboxane synthetase inhibition in normal and hyperdynamic endotoxemic rabbits.
    Fink MP; Morrissey PE; Stein KL; Clement RE; Fiallo V; Gardiner WM
    Circ Shock; 1988 Sep; 26(1):41-57. PubMed ID: 3142697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediators of acute lung injury in endotoxaemia.
    Parratt JR; Pacitti N; Rodger IW
    Prog Clin Biol Res; 1989; 308():357-69. PubMed ID: 2506570
    [No Abstract]   [Full Text] [Related]  

  • 5. Arachidonic acid enhances the tissue factor expression of mononuclear cells by the cyclo-oxygenase-1 pathway: beneficial effect of n-3 fatty acids.
    Cadroy Y; Dupouy D; Boneu B
    J Immunol; 1998 Jun; 160(12):6145-50. PubMed ID: 9637532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of thromboxane and prostacyclin in endotoxic and septic shock.
    Cook JA; Wise WC; Butler RR; Reines HD; Rambo W; Halushka PV
    Am J Emerg Med; 1984 Jan; 2(1):28-37. PubMed ID: 6440569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostaglandin synthetase components (author's transl)].
    Robak J; Kasperczyk H
    Postepy Biochem; 1979; 25(4):547-63. PubMed ID: 120943
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of inhibitors of the activity of cyclo-oxygenase-2 on the hypotension and multiple organ dysfunction caused by endotoxin: a comparison with dexamethasone.
    Leach M; Hamilton LC; Olbrich A; Wray GM; Thiemermann C
    Br J Pharmacol; 1998 Jun; 124(3):586-92. PubMed ID: 9647485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic pathways of arachidonic acid: prostaglandins, thromboxane and leukotrienes].
    Maclouf J
    Arch Mal Coeur Vaiss; 1985 Dec; 78 Spec No():21-7. PubMed ID: 3938940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosanoids, signal molecules of liver cells.
    Decker K
    Semin Liver Dis; 1985 May; 5(2):175-90. PubMed ID: 3927486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin: a prostaglandin with therapeutic potential.
    Vane JR
    Arch Farmacol Toxicol; 1982 Aug; 8(2):51-76. PubMed ID: 6818907
    [No Abstract]   [Full Text] [Related]  

  • 12. [Specific cyclo-oxygenase-2 inhibitors in cardiovascular pathology].
    Monsuez JJ
    Arch Mal Coeur Vaiss; 2004 Jun; 97(6):632-40. PubMed ID: 15283037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis.
    Dogné JM; Hanson J; Pratico D
    Trends Pharmacol Sci; 2005 Dec; 26(12):639-44. PubMed ID: 16243403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of eicosanoids in mediating blood flow alterations in endotoxin shock.
    Tempel GE; Strong JW; Wise WC; Cook JA; Smith EF; Halushka PV
    Prog Clin Biol Res; 1989; 299():33-42. PubMed ID: 2498907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 inhibitors and metabolism of essential fatty acids.
    Das UN
    Med Sci Monit; 2005 Jul; 11(7):RA233-7. PubMed ID: 15990700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cyclo-oxygenase and thromboxane synthetase inhibitors on right atrial prostaglandins.
    Madan ZM; Sainani GS
    J Assoc Physicians India; 2000 Jun; 48(6):581-3. PubMed ID: 11273534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.
    Chiabrando C; Broggini M; Castelli MG; Cozzi E; Castagnoli MN; Donelli MG; Garattini S; Giavazzi R; Fanelli R
    Cancer Res; 1987 Feb; 47(4):988-91. PubMed ID: 3100032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of vascular thrombosis by products of arachidonic acid metabolism.
    Wu KK; Hall ER; Papp A
    Clin Physiol Biochem; 1984; 2(2-3):84-90. PubMed ID: 6435930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
    Hardee MM; Moore JN; Hardee GE
    Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and metabolism of prostaglandins, prostacyclin, and thromboxanes: the arachidonic acid cascade.
    Ramwell PW; Foegh M; Loeb R; Leovey EM
    Semin Perinatol; 1980 Jan; 4(1):3-13. PubMed ID: 6247764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.